ACC AHA guidelines for evaluation of unoperated patients with atrial septal defects
Atrial Septal Defect Microchapters | |
Treatment | |
---|---|
Surgery | |
| |
Special Scenarios | |
Case Studies | |
ACC AHA guidelines for evaluation of unoperated patients with atrial septal defects On the Web | |
American Roentgen Ray Society Images of ACC AHA guidelines for evaluation of unoperated patients with atrial septal defects | |
FDA on ACC AHA guidelines for evaluation of unoperated patients with atrial septal defects | |
CDC on ACC AHA guidelines for evaluation of unoperated patients with atrial septal defects | |
ACC AHA guidelines for evaluation of unoperated patients with atrial septal defects in the news | |
Blogs on ACC AHA guidelines for evaluation of unoperated patients with atrial septal defects | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [4]
Overview
Different modalities of treatment could be used to diagnose and determine the amount of shunting across the atrial septal defect. Maximal exercise testing can be used in patients with symptoms that are discrepant with clinical findings or to document changes in oxygen saturation in patients with mild or moderate pulmonary artery hypertension[1].
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[2]
Recommendations for Atrial Septal Defect
Class I |
1.Pulse oximetry at rest and during exercise is recommended for evaluation of adults with unrepaired or repaired ASD with residual shunt to determine the direction and magnitude of the shunt. (Level of Evidence: C-EO) |
2.CMR, CCT, and/or TEE are useful to evaluate pulmonary venous connections in adults with ASD. (Level of Evidence: B-NR) |
3.Echocardiographic imaging is recommended to guide percutaneous ASD closure.(Level of Evidence: B-NR) |
2008 ACC/AHA Guidelines for the Management of Adults With Congenital Heart Disease (DO NOT EDIT)[1]
Recommendations for Evaluation of the Unoperated Patient (DO NOT EDIT)[1]
Class I |
"1. ASD should be diagnosed by imaging techniques with demonstration of shunting across the defect and evidence of RV volume overload and any associated anomalies. (Level of Evidence: C) " |
"2. Patients with unexplained RV volume overload should be referred to an ACHD center for further diagnostic studies to rule out obscure ASD, partial anomalous venous connection, or coronary sinoseptal defect.(Level of Evidence: C)" |
Class III |
"1. In younger patients with uncomplicated ASD for whom imaging results are adequate, diagnostic cardiac catheterization is not indicated. (Level of Evidence: B) " |
"2. Maximal exercise testing is not recommended in ASD with severe PAH. (Level of Evidence: B)" |
Class IIa |
"1. Maximal exercise testing can be useful to document exercise capacity in patients with symptoms that are discrepant with clinical findings or to document changes in oxygen saturation in patients with mild or moderate PAH. (Level of Evidence: C) " |
"2. Cardiac catheterization can be useful to rule out concomitant coronary artery disease in patients at risk because of age or other factors. (Level of Evidence: B) " |
References
- ↑ 1.0 1.1 1.2 Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA; et al. (2008). "ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (23): e1–121. doi:10.1016/j.jacc.2008.10.001. PMID 19038677.
- ↑ Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM; et al. (2019). "2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". J Am Coll Cardiol. 73 (12): 1494–1563. doi:10.1016/j.jacc.2018.08.1028. PMID 30121240.